ACW
ACTINOGEN FPO [ACW]
Healthcare · ASX Small Cap
$0.0410 +0.0%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +5First seen: 2026-02-25
Score Breakdown
Technical57
Catalyst60
Sentiment50
Fundamental31
Momentum62
Risk Gate45
Active Signals
Bullish Signals
- RSI approaching oversold
- Bollinger squeeze (breakout building)
- Volatility contracting (breakout setup)
- Above 200-day MA (long-term uptrend)
- Strong cash runway (9 quarters)
- Revenue in sharp decline (-39%)
- Recent placement detected - dilution risk
- Strong 12-1 momentum (+80%)
- Low-priced stock risk ($0.041)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE2 (est. 2019-03-15)
Risk Signals
- Price below MAs (downtrend)
- Negative 5-day momentum (-4.7%)
- Piotroski F-Score weak (2/9)
- Deeply negative margins (-268%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-39%)
Recent Catalysts
NONE Application for quotation of securities - ACW
NONE Application for quotation of securities - ACW
NONE ACW HY26 results - XanaMIA pivotal Alzheimers trial progress
MEDIUM ACW successfully completes $16.8m Placement and SPP
Announcement tone +3pts
Recent ASX Announcements
| 2026-03-01 | Application for quotation of securities - ACW |
| 2026-02-26 | ACW successfully completes $16.8m Placement and SPP PRICE SENSITIVE |
| 2026-02-26 | Application for quotation of securities - ACW |
| 2026-02-25 | ACW HY26 results - XanaMIA pivotal Alzheimers trial progress PRICE SENSITIVE |
| 2026-02-25 | Actinogen HY2025 financial report and Appendix 4D PRICE SENSITIVE |
Key Metrics
$141.9M
Market Cap
4.3M
Avg Volume
0.9x
Vol Ratio
$0.02 — $0.07
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-77.5%
ROE
-268.4%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 73% |
| L | Leader vs Laggard | laggard | RS: -5 |
| I | Institutional Sponsorship | weak | Inst: 2% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #26 of 119 · Sector avg: 51
View all Healthcare signals →